Sinopharm vaccine is expected to be included in the COVAX plan in the next few weeks or months.
The World Health Organization (WHO) has authorized emergency use COVID-19 vaccine Manufactured by a pharmaceutical factory China National Medicines.
This decision was made by the WHO Technical Advisory Group, which may lead to Sinopharm Vaccine Included in the next few weeks or months COVAX program With the support of the United Nations. In this way, it can be distributed through UNICEF and the WHO Regional Office for the Americas.
Sinopharm Holdings Except for some performance indicators of its two vaccines, almost no data was released: one was developed by the Beijing Institute of Biology, and the other was developed by the Wuhan Institute of Biology. The WHO reviewed the emergency use list of Beijing vaccines.
Please also read: Are these the least effective Covid-19 vaccines?
Another group that provides vaccine advisory services to the United Nations agency said that the “Sinopharm” vaccine can protect people aged 18 to 59, which is “very confident”, but it is only “low-level” for its efficacy in people over 60. confidence”.